METiS TechBio

METiS Therapeutics is a biotechnology company that integrates artificial intelligence, machine learning, and high-throughput experimentation to accelerate drug discovery and delivery. The company's proprietary AiM™ platform optimizes both the molecular structure of therapeutics and their delivery mechanisms, with a particular focus on small molecules and mRNA-based medicines. METiS aims to address unmet medical needs in oncology, immunology, and central nervous system disorders by overcoming traditional formulation and delivery challenges. Headquartered in Cambridge, Massachusetts, the company leverages its cross-disciplinary expertise to develop a robust internal pipeline while seeking strategic partnerships to expand its impact.